Nasdaq · CIK 0001429260
FBIO Fortress Biotech, Inc.
Insider trading from SEC Form 4. Last filing 12 d ago.
Fortress Biotech, Inc. (FBIO) has 21 SEC Form 4 filings on file from 9 insiders, the latest filed on Oct 1, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Fortress Biotech, Inc., scored.
Transactions
Every row filed, 21 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | David Jin Chief Financial Officer | AGrant or award Common Stock, par value $0.001 | +1,190 | $1.82 | $2,165 | 1,652,761 | 12 d ago |
| Jun 22, 2026 | David Jin Chief Financial Officer | AGrant or award Common Stock, par value $0.001 | +400,000 | $0.00 | $0 | 1,651,571 | Jun 24, 2026 |
| Apr 1, 2026 | David Jin Chief Financial Officer | AGrant or award Common Stock, par value $0.001 | +2,967 | $2.18 | $6,456 | 1,251,571 | Apr 1, 2026 |
| Mar 18, 2026 | Lindsay A Rosenwald Md PRESIDENT, CEO & CHAIRMAN | AGrant or award Common stock, par value $0.001 | +475,424 | $0.00 | $0 | 4,586,841 | Mar 20, 2026 |
| Mar 18, 2026 | Michael S Weiss Executive Vice Chairman | AGrant or award common stock, par value $0.001 | +475,424 | $0.00 | $0 | 2,276,562 | Mar 20, 2026 |
| Jan 1, 2026 | J Jay Lobell director | AGrant or award common stock, par value $0.001 | +27,322 | $0.00 | $0 | 192,397 | Jan 5, 2026 |
| Jan 1, 2026 | Malcolm Hoenlein director | AGrant or award Common Stock, par value $0.001 | +27,322 | $0.00 | $0 | 115,747 | Jan 5, 2026 |
| Jan 1, 2026 | Jimmie Harvey director | AGrant or award common stock, par value $0.001 | +27,322 | $0.00 | $0 | 146,704 | Jan 5, 2026 |
| Jan 1, 2026 | Dov Klein director | AGrant or award common stock, par value $0.001 | +27,322 | $0.00 | $0 | 130,105 | Jan 5, 2026 |
| Jan 1, 2026 | Kevin Lorenz director | AGrant or award common stock, par value $0.001 | +27,322 | $0.00 | $0 | 101,009 | Jan 5, 2026 |
| Oct 1, 2025 | David Jin Chief Financial Officer | AGrant or award Common Stock, par value $0.001 | +2,711 | $1.31 | $3,549 | 1,248,604 | Oct 2, 2025 |
| Apr 1, 2025 | David Jin Chief Financial Officer | AGrant or award Common Stock, par value $0.001 | +5,000 | $1.22 | $6,078 | 1,245,893 | Apr 1, 2025 |
| Jan 1, 2025 | Lindsay A Rosenwald Md PRESIDENT, CEO & CHAIRMAN | AGrant or award Common stock, par value $0.001 | +454,153 | $0.00 | $0 | 4,111,417 | Jan 3, 2025 |
| Jan 1, 2025 | Michael S Weiss Executive Vice Chairman | AGrant or award common stock, par value $0.001 | +454,153 | $0.00 | $0 | 1,801,138 | Jan 3, 2025 |
| Jan 1, 2025 | Malcolm Hoenlein director | AGrant or award Common Stock, par value $0.001 | +49,383 | $0.00 | $0 | 88,425 | Jan 3, 2025 |
| Jan 1, 2025 | Kevin Lorenz director | AGrant or award common stock, par value $0.001 | +49,383 | $0.00 | $0 | 73,687 | Jan 3, 2025 |
| Jan 1, 2025 | Jimmie Harvey director | AGrant or award common stock, par value $0.001 | +49,383 | $0.00 | $0 | 119,382 | Jan 3, 2025 |
| Jan 1, 2025 | Lucy Lu director | AGrant or award common stock, par value $0.001 | +49,383 | $0.00 | $0 | 61,273 | Jan 3, 2025 |
| Jan 1, 2025 | Dov Klein director | AGrant or award common stock, par value $0.001 | +49,383 | $0.00 | $0 | 102,783 | Jan 3, 2025 |
| Jan 1, 2025 | J Jay Lobell director | AGrant or award common stock, par value $0.001 | +49,383 | $0.00 | $0 | 165,075 | Jan 3, 2025 |
| Dec 19, 2024 | David Jin Chief Financial Officer | AGrant or award Common Stock, par value $0.001 | +1,000,000 | $0.00 | $0 | 1,240,893 | Dec 23, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Jimmie Harveydirector
- Malcolm Hoenleindirector
- David JinChief Financial Officer
- Dov Kleindirector
- J Jay Lobelldirector
- Kevin Lorenzdirector
- Lucy Ludirector
- Lindsay A Rosenwald MdPRESIDENT, CEO & CHAIRMAN
- Michael S WeissExecutive Vice Chairman
Questions about FBIO
Answered from the filings on this page, as of the latest one.
Are insiders buying FBIO?
No. In the last 90 days no insider at Fortress Biotech, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade FBIO on the open market?
No open-market trade has been scored at Fortress Biotech, Inc.. The latest Form 4 on file was filed on Oct 1, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Fortress Biotech, Inc.?
9 people have filed a Form 4 at Fortress Biotech, Inc., among them Jimmie Harvey (director), Malcolm Hoenlein (director), David Jin (Chief Financial Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.